A case of pompholyx after intravenous immunoglobulin therapy
- Authors
- 유서례; 오지구; 노영석
- Issue Date
- Feb-2007
- Publisher
- 대한피부과학회
- Keywords
- Intravenous immunoglobulin; Pompholyx
- Citation
- Korean Journal of Dermatology, v.45, no.2, pp.200 - 202
- Indexed
- SCOPUS
KCI
- Journal Title
- Korean Journal of Dermatology
- Volume
- 45
- Number
- 2
- Start Page
- 200
- End Page
- 202
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/180465
- ISSN
- 0494-4739
- Abstract
- Intravenous immunoglobulin therapy has been used to treat various immune- mediated diseases. Its utility in dermatology continues to expand, including treatment for autoimmune blistering disease, graft-versus-host disease, and dermatomyositis. It is generally considered safe, and serious adverse effects such as anaphylaxis, renal tubular necrosis or aseptic meningitis rarely occur. Furthermore, adverse skin reactions very rarely occur, but can include urticaria, pruritus, eczema, alopecia, lichenoid dermatitis or pompholyx. We describe a case of a 48-year-old man who developed vesicular eczema on his palms and soles after administration of intravenous immunoglobulin therapy for encephalomyelopathy.
- Files in This Item
-
Go to Link
- Appears in
Collections - 서울 의과대학 > 서울 피부과학교실 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.